Use of the method of transmural nerve stimulation depends on the assumption that stimulation parameters can be chosen to selectively and maximally activate nerves without stimulating vascular smooth muscle directly. When commercial stimulators are used with low impedance electrodes, it may not be possible to validate this assumption, due to the limited current output in this situation. To circumvent this limitation a coupling device which provides a very low source impedance to the electrodes is described. Using this device in experiments on preparations of rabbit ear artery, we have demonstrated that it is possible to selectively activate nerves, without stimulating smooth muscle directly. Adrenergic nerve activation was blocked with guanethidine, phentolamine or tetrodotoxin, while responses to direct smooth muscle activation persist in the presence of these drugs. Appropriate parameters for supramaximal nerve stimulation vary with the type of preparation and electrode arrangement. The possibility of variation with tissue and species is also discussed.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.